英国179例代孕案例首次临床报告:对政策与实践的启示
该回顾性队列研究分析了两家英国HFEA监管的IVF中心2014年至2021年9月间的代孕治疗,发现代孕治疗数量及同性男性意向父母占比逐年增加,108位代孕者中61位分娩71名婴儿,异性夫妇与同性男性夫妇活产率无显著差异,新鲜与玻璃化卵母细胞活产率亦无显著差异。
要点
- 代孕治疗数量及同性男性意向父母占比逐年上升。
- 异性夫妇与同性男性夫妇活产率无统计学显著差异。
- 玻璃化卵母细胞使用逐年增加,新鲜卵母细胞使用自2019年峰值后下降,两者活产率无显著差异。
核心结论
- 代孕治疗数量稳步增加,同性男性夫妇占比是该增长的主要贡献因素。
- 玻璃化/复苏卵母细胞使用已超过新鲜卵母细胞。
- 结果为支持英国2022年晚些时候预期引入的监管改革自由化提供了有力基础。
研究设计与样本
- 回顾性队列研究,分析2014年至2021年9月期间两家英国HFEA监管的IVF中心(伦敦、卡迪夫)的代孕治疗。
- 共108位代孕者,截至2022年2月,61位代孕者分娩71名婴儿,另有5例妊娠 ongoing。
主要发现
- 代孕治疗数量及同性男性意向父母所占比例在研究期间逐年增加。
- 异性夫妇与同性男性夫妇的活产率无统计学显著差异。
- 单人和跨性别意向父母的样本量太小(n < 5),无法比较。
- 玻璃化卵母细胞使用逐年增加,新鲜卵母细胞使用自2019年峰值后下降。
- 整个队列中,新鲜与玻璃化卵母细胞使用的活产率无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 单人和跨性别意向父母的样本量太小(n < 5),无法比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What implications for policy and practice can be derived from outcomes and trends observed across 8 years of a surrogacy programme in two UK-regulated IVF centres (London, Cardiff)? DESIGN: Retrospective cohort study analysing surrogacy treatments undertaken between 2014 and September 2021. RESULTS: Surrogacy continues to rise in popularity in the UK despite the inability of those supporting safe and professional practice to advertise to recruit surrogates. In two IVF centres regulated by the Human Fertilisation and Embryology Authority (HFEA), both the number of surrogacy treatments and the proportion of those undertaken on behalf of same-sex male intended parents increased year on year in the period studied. From a cohort of 108 surrogates, 71 babies were born to 61 surrogates (with five pregnancies ongoing) by February 2022. No statistically significant difference in live birth rates (LBR) was observed between the heterosexual couples and same-sex male couples. Sample sizes of single and transgender intended parents were too small (n < 5) to compare. The use of vitrified oocytes in surrogacy treatments has increased year on year, while fresh oocyte use has declined since peaking in 2019. There was no significant difference in LBR between fresh and vitrified oocyte usage across the cohort. CONCLUSIONS: The number of surrogacy treatments steadily increased, with clear evidence that the proportion of same-sex male couples accessing surrogacy is a major contributor to this growth. Vitrified/warmed oocyte use now outstrips the use of fresh oocytes in the surrogacy treatment cycles studied here. The results represent a strong basis for supporting the liberalization of regulatory reform expected to be introduced in the UK later in 2022.
引用
- Horsey K, Gibson G, Lamanna G, et al. First clinical report of 179 surrogacy cases in the UK: implications for policy and practice. Reprod Biomed Online. 2022. PMID: 35907684. doi:10.1016/j.rbmo.2022.05.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。